首页> 外文期刊>Molecular biology reports >Detection of HBB:c.92+5G>C and HBB:c.108delC mutations in beta-thalassemia carriers using high-resolution melting analysis
【24h】

Detection of HBB:c.92+5G>C and HBB:c.108delC mutations in beta-thalassemia carriers using high-resolution melting analysis

机译:检测HBB:C.92 + 5g> C和HBB:C.108DelC使用高分辨率熔化分析的β-地中海贫血血症突变

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The HBB:c.92+5G>C [known as IVSI-5 (GC)] and HBB:c.108delC [known as Cd 35 (del C)] are the beta-globin gene mutations that commonly found in Indonesia. Detection of the mutation in the beta-thalassemia carriers can be useful to prevent an increase in the number of beta-thalassemia patients. High-Resolution Melting Analysis (HRMA) is the method that can detect the mutation rapidly. The aim of this study was to detect HBB:c.92+5G>C and HBB:c.108delC mutations of the beta-thalassemia carriers using HRMA. DNA was isolated from blood archive of ten hematologically proved beta-thalassemia carriers. Detection of mutations was carried out by HRMA and then confirmed by sequencing. HRMA was performed by using two pairs of specific primers. One pair of primer targeted the region of HBB:c.92+5G>C and the other targeted the region of HBB:c.108delC. The results of detection of mutation using HRMA then were confirmed by sequencing. A specific primer pair covering the region of HBB:c.92+5G>C to HBB:c.108delC were used for sequencing. The results of HRMA showed that the HBB:c.92+5G>C and HBB:c.108delC mutations found in 50% and 30% samples, respectively. The HRMA results can be confirmed by sequencing in all samples. It can be concluded that HRMA can be used to detect HBB:c.92+5G>C heterozygote and HBB:c.108delC heterozygote mutations.
机译:HBB:C.92 + 5G> C [称为IVSI-5(GC)]和HBB:C.108DelC [称为CD 35(Del C)]是常见于印度尼西亚的β-珠蛋白基因突变。检测β-地中海贫血血症载体中的突变可用于防止β-地中海贫血患者的数量增加。高分辨率熔化分析(HRMA)是可以快速检测突变的方法。本研究的目的是检测HBB:C.92 + 5g> C和HBB:使用HRMA的β-血症血症携带者的C.108DelC突变。 DNA从10个血液学上被证明的β-地中海贫血血症携带者的血液归档中分离出来。通过HRMA检测突变,然后通过测序确认。通过使用两对特异性引物进行HRMA。一对引物靶向HBB的区域:C.92 + 5g> C,另一个靶向HBB:C.108DelC的区域。然后通过测序确认使用HRMA检测突变的结果。覆盖HbB的区域:C.92 + 5g> C至HbB:C.108DelC的特异性引物对进行测序。 HRMA的结果表明,HBB:C.92 + 5g> C和HBB:C.108DelC突变分别在50%和30%的样品中发现。可以通过在所有样品中测序来确认HRMA结果。可以得出结论,HRMA可用于检测HBB:C.92 + 5G> C杂合子和HBB:C.108DelC杂合子突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号